Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist

Journal of Reproductive Immunology

Volumn 90, Issue 2, 2011, Pages 227-234

  Matsui, Sumika ^a   Yasui, Toshiyuki ^a   Uemura, Hirokazu ^a   Yamamoto, Satoshi ^a   Matsuzaki, Toshiya ^a   Tsuchiya, Naoko ^b   Yuzurihara, Mitsutoshi ^b   Kase, Yoshio ^b   Irahara, Minoru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Tsumura Central Research Institute   (Japan)

Author keywords

Estrogen; GnRH agonist; MCP1

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GONADORELIN AGONIST; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTROGEN DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; UTERUS MYOMA;

ADULT; CHEMOKINE CCL2; CYTOKINES; E-SELECTIN; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEIOMYOMA; LEUPROLIDE; TIME FACTORS; UTERINE NEOPLASMS;

EID: 79960254975     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.04.011     Document Type: Article

References (26)

1. Cioffi M., Esposito K., Vietri M.T., Gazzerro P., D'Auria A., Ardovino I., Puca G.A., Molinari A.M. Cytokine pattern in postmenopause. Maturitas 2002, 41:187-192.
2. Deguchi K., Kamada M., Irahara M., Maegawa M., Yamamoto S., Ohmoto Y., Murata K., Yasui T., Yamamo S., Aono T. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 2001, 8(4):266-273.
3. Farzati A., Esposito K., Colacurci N., Fornaro F., Chiantera V., Farzati B. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women. Fertil. Steril. 2002, 77:476-480.
4. Hong S.C., Yoo S.W., Cho G.J., Kim T., Hur J.Y., Park Y.K., Lee K.W., Kim S.H. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 2007, 14(5):835-840.
5. Kamada M., Irahara M., Maegawa M., Ohmoto Y., Takeji T., Yasui T., Aono T. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am. J. Obstet. Gynecol. 2001, 184:309-314.
6. Kim C.S., Park H.S., Kawada T., Kim J.H., Lim D., Hubbard N.E., Kwon B.S., Erickson K.L., Yu R. Circulating levels of MCP1 and IL8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. 2006, 30:1347-1355.
7. Khan K.N., Kitajima M., HIraki K., Fujishita A., Sekine I., Ishimaru T., Masuzaki H. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum. Reprod. 2010, 25(3):642-653.
8. Lang T.J. Estrogen as an immunomodulator. Clin. Immunol. 2004, 113:224-230.
9. Miller A.P., Feng W., Xing D., Weathington N.M., Blalock E., Chen Y.F., Oparil S. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 2004, 110:1664-1669.
10. Noguchi M., Yuzurihara M., Kase Y., Yasui T., Irahara M. Involvement of cytokine-induced neutrophil chemoattractant in hypothalamic thermoregulation of luteinizing hormone-releasing hormone. Endocrinology 2008, 149:2899-2906.
11. Porter V.R., Greendale G.A., Schocken M., Zhu X., Effros R.B. Immune effects of hormone replacement therapy in postmenopausal women. Exp. Gerontol. 2001, 36:311-326.
12. Phiel K.L., Henderson R.A., Adelman S.J., Elloso M.M. Differential estrogen receptor gene expression in human perineal blood mononuclear cell populations. Immunol. Lett 2005, 97:107-113.
13. Reape T.J., Groot P.H. Chemokines and atherosclerosis. Atherosclerosis 1999, 147:213-225.
14. Sozen I., Senturk L.M., Arici A. Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus. Fertil. Steril. 2001, 76:792-796.
15. Senturk L.M., Sozen I., Gutierrez L., Arici A. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma. Am. J. Obstet. Gynecol. 2001, 184:559-566.
16. Seli E., Pehlivan T., Selam B., Garcia-Velasco J.A., Arici A. Estradiol down-regulates MCP1 expression in human coronary artery endothelial cells. Fertil. Steril. 2002, 77:542-547.
17. Stork S., von Schacky C., Angerer P. The effect of 17β-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 2002, 165:301-307.
18. Stork S., Baumann K., von Schacky C., Angerer P. The effect of 17β-estradiol on MCP1 serum levels in postmenopausal women. Cardiovasc Res 2002, 53:642-649.
19. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J. Clin. Endocrinol. Metab. 2002, 87:4602-4606.
20. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
21. US Department of Health and Human Service, Food and Drug Administration, Center for Drug Evaluation and Research, 2003. Guidance for Industry: Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms - Recommendations for Clinical Evaluation. Division of Drug Information, Center for Drug Evaluation and Research, Rockville, MD.
22. Xia X., Zhang S., Yu Y., Zhao N., Liu R., Liu K., Chen X. Effects of replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. J. Reprod. Immunol. 2009, 81:89-96.
23. Yasui T., Uemura H., Tomita J., Miyatani Y., Yamada M., Kuwahara A., Matsuzaki T., Maegawa M., Tsuchiya N., Yuzurihara M., Takeda S., Irahara M. Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J. Clin. Endocrinol. Metab. 2006, 91:4805-4808.
24. Yasui T., Maegawa M., Tomita J., Miyatani Y., Yamada M., Uemura H., Matsuzaki T., Kuwahara A., Kamada M., Tsuchiya N., Yuzurihara M., Takeda S., Irahara M. Changes in serum cytokine concentrations during the menopausal transition. Maturitas 2007, 56:396-403.
25. Yasui T., Saijo A., Uemura H., Matsuzaki T., Tsuchiya N., Yuzurihara M., Kase Y., Irahara M. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy. Eur. J. Endocrinol. 2009, 161:267-273.
26. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:5252-5256.